Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination.

Lee, Adrian Y S; Lee, Caroline; Brown, David A; Suan, Dan

Lee, Adrian Y S; Lee, Caroline; Brown, David A; Suan, Dan.

Lee AYS; Westmead Hospital, Westmead, New South Wales, Australia.
Lee C; Department of Immunopathology, Institute for Clinical Pathology and Medical Research & NSW Health Pathology, Westmead, NSW, Australia.
Brown DA; Westmead Clinical School, The University of Sydney, Westmead, NSW, Australia.
Suan D; Westmead Hospital, Westmead, New South Wales, Australia.

Postgrad Med J ; 99(1170): 363-364, 2023 05 22.

Article in English | MEDLINE | ID: covidwho-20238468

Subject(s)

COVID-19; Dermatomyositis; Humans; BNT162 Vaccine; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Vaccination

Keywords

adult dermatology; immunology; neurology; rheumatology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dermatomyositis / COVID-19 Type of study: Case report Topics: Vaccines Limits: Humans Language: English Journal: Postgrad Med J Year: 2023 Document Type: Article Affiliation country: Postgradmedj-2022-141510

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google